Literature DB >> 12636106

Effect of Withania somnifera on cell mediated immune responses in mice.

L Davis1, G Kuttan.   

Abstract

Effect of Withania somnifera on the cellular immune responses (CMI) was studied in normal as well as tumour bearing animals. Administration of Withania extract was found to enhance the proliferation of lymphocytes, bone marrow cells and thymocytes in responses to mitogens. Both PHA and Con A mitogens along with Withania treated splenocytes, bone marrow cells and thymocytes could stimulate proliferation twice greater than the normal. Withania treated splenocytes along with the mitogen LPS (10 microg/ml) could stimulate the lymphocyte proliferation six times more than the normal. Natural killer cell activity (NK) was found to be enhanced significantly in both the normal and the tumour bearing group and it was found to be earlier than the control (48.92% cell lysis). Antibody dependent cellular cytotoxicity (ADCC) was found to be enhanced in the Withania treated group on the 9th day (65% cell lysis). An early Antibody dependent complement mediated cytotoxicity (ACC) was observed in the Withania treated group on day 13 (47% cell lysis).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12636106

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  10 in total

Review 1.  A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.

Authors:  Eun-Ryeong Hahm; Su-Hyeong Kim; Krishna B Singh; Kamayani Singh; Shivendra V Singh
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-29

Review 2.  Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha.

Authors:  Caroline Joseph Kiriacos; Monika Rafik Khedr; Miray Tadros; Rana A Youness
Journal:  Front Oncol       Date:  2022-05-18       Impact factor: 5.738

Review 3.  Botanical immunodrugs: scope and opportunities.

Authors:  Bhushan Patwardhan; Manish Gautam
Journal:  Drug Discov Today       Date:  2005-04-01       Impact factor: 7.851

Review 4.  Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective.

Authors:  Sumaira Saleem; Gulzar Muhammad; Muhammad Ajaz Hussain; Muhammad Altaf; Syed Nasir Abbas Bukhari
Journal:  Iran J Basic Med Sci       Date:  2020-12       Impact factor: 2.699

Review 5.  A Perspective on Withania somnifera Modulating Antitumor Immunity in Targeting Prostate Cancer.

Authors:  Seema Dubey; Manohar Singh; Ariel Nelson; Dev Karan
Journal:  J Immunol Res       Date:  2021-08-25       Impact factor: 4.818

Review 6.  Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy.

Authors:  Manali Singh; Kuldeep Jayant; Dipti Singh; Shivani Bhutani; Nitesh Kumar Poddar; Anis Ahmad Chaudhary; Salah-Ud-Din Khan; Mohd Adnan; Arif Jamal Siddiqui; Md Imtaiyaz Hassan; Faez Iqbal Khan; Dakun Lai; Shahanavaj Khan
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

7.  Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells.

Authors:  Babli Halder; Shruti Singh; Suman S Thakur
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

Review 8.  Plants and phytochemicals for Huntington's disease.

Authors:  Sunayna Choudhary; Puneet Kumar; Jai Malik
Journal:  Pharmacogn Rev       Date:  2013-07

Review 9.  Natural Withanolides in the Treatment of Chronic Diseases.

Authors:  Peter T White; Chitra Subramanian; Hashim F Motiwala; Mark S Cohen
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 10.  Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations.

Authors:  Sukriti Vishwas; Monica Gulati; Bhupinder Kapoor; Saurabh Gupta; Sachin Kumar Singh; Ankit Awasthi; Arzoo Khan; Aditya Goyal; Anil Bansal; Suman Baishnab; Thakur Gurjeet Singh; Sandeep Arora; Omji Porwal; Ankit Kumar; Vijay Kumar
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.